Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica N Peters

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
European Journal of Clinical Pharmacology|October 19, 2021
Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ<sup>9</sup>-tetrahydrocannabinol: a pilot studyErica N Peters, Laura MacNair, Irina Mosesova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2012
Tobacco assessment in actively accruing National Cancer Institute Cooperative Group Program Clinical TrialsErica N Peters, Essie Torres, Benjamin A Toll, et al.
Experimental and Clinical Psychopharmacology|October 5, 2023
A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep qualityMarcel O Bonn-Miller, Matthew T Feldner, Teah M Bynion, et al.
Pain|October 16, 2019
Cannabinoid effects on responses to quantitative sensory testing among individuals with and without clinical pain: a systematic reviewChung Jung Mun, Janelle E Letzen, Erica N Peters, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Pharmacokinetics of Oral Cannabinoid Δ8-Tetrahydrocannabivarin and Its Main Metabolites in Healthy ParticipantsCristina Sempio, Jorge Campos-Palomino, Jelena Klawitter, et al.
Experimental and Clinical Psychopharmacology|May 29, 2020
Impact of smoked cannabis on tobacco cigarette smoking intensity and subjective effects: A placebo-controlled, double-blind, within-subjects human laboratory studyErica N Peters, Evan S Herrmann, Carson Smith, et al.
Experimental and Clinical Psychopharmacology|April 25, 2022
A crowdsourcing survey study on the subjective effects of delta-8-tetrahydrocannabinol relative to delta-9-tetrahydrocannabinol and cannabidiolCecilia L Bergeria, Justin C Strickland, Tory R Spindle, et al.
International Review of Psychiatry (Abingdon, England)|September 5, 2018
Sweet flowers are slow, and weeds make haste: leveraging methodology from research on tobacco, alcohol, and opioid analgesics to make rapid and policy-relevant advances in cannabis scienceEvan S Herrmann, Brantley P Jarvis, Alicia C Sparks, et al.
Forensic Toxicology|June 6, 2026
Metabolite patterns in human urine after oral administration of highly purified Δ8-THCVCristina Sempio, Jorge Campos-Palomino, Jelena Klawitter, et al.
Journal of Analytical Toxicology|June 5, 2024
LC-MS-MS quantification of Δ8-THC, Δ9-THC, THCV isomers and their main metabolites in human plasmaCristina Sempio, Jorge Campos-Palomino, Jelena Klawitter, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
European Journal of Clinical Pharmacology|October 19, 2021
Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ<sup>9</sup>-tetrahydrocannabinol: a pilot studyErica N Peters, Laura MacNair, Irina Mosesova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2012
Tobacco assessment in actively accruing National Cancer Institute Cooperative Group Program Clinical TrialsErica N Peters, Essie Torres, Benjamin A Toll, et al.
Experimental and Clinical Psychopharmacology|October 5, 2023
A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep qualityMarcel O Bonn-Miller, Matthew T Feldner, Teah M Bynion, et al.
Pain|October 16, 2019
Cannabinoid effects on responses to quantitative sensory testing among individuals with and without clinical pain: a systematic reviewChung Jung Mun, Janelle E Letzen, Erica N Peters, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Pharmacokinetics of Oral Cannabinoid Δ8-Tetrahydrocannabivarin and Its Main Metabolites in Healthy ParticipantsCristina Sempio, Jorge Campos-Palomino, Jelena Klawitter, et al.
Experimental and Clinical Psychopharmacology|May 29, 2020
Impact of smoked cannabis on tobacco cigarette smoking intensity and subjective effects: A placebo-controlled, double-blind, within-subjects human laboratory studyErica N Peters, Evan S Herrmann, Carson Smith, et al.
Experimental and Clinical Psychopharmacology|April 25, 2022
A crowdsourcing survey study on the subjective effects of delta-8-tetrahydrocannabinol relative to delta-9-tetrahydrocannabinol and cannabidiolCecilia L Bergeria, Justin C Strickland, Tory R Spindle, et al.
International Review of Psychiatry (Abingdon, England)|September 5, 2018
Sweet flowers are slow, and weeds make haste: leveraging methodology from research on tobacco, alcohol, and opioid analgesics to make rapid and policy-relevant advances in cannabis scienceEvan S Herrmann, Brantley P Jarvis, Alicia C Sparks, et al.
Forensic Toxicology|June 6, 2026
Metabolite patterns in human urine after oral administration of highly purified Δ8-THCVCristina Sempio, Jorge Campos-Palomino, Jelena Klawitter, et al.
Journal of Analytical Toxicology|June 5, 2024
LC-MS-MS quantification of Δ8-THC, Δ9-THC, THCV isomers and their main metabolites in human plasmaCristina Sempio, Jorge Campos-Palomino, Jelena Klawitter, et al.
Pageof 9